Related Experiment Video
Updated: Aug 3, 2025
10:46
A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Published on: September 13, 2022
3.7K
Aptamer-Based Strategies to Boost Immunotherapy in TNBC
Lisa Agnello1, Annachiara d'Argenio1, Roberto Nilo1
1Institute of Experimental Endocrinology and Oncology "Gaetano Salvatore", CNR, Via S. Pansini 5, 80131 Naples, Italy.
Cancers
|April 13, 2023
Summary
Aptamers show promise in enhancing the immune system's (IS) ability to combat triple-negative breast cancer (TNBC). These novel strategies aim to overcome immune evasion and improve immunotherapy effectiveness for TNBC patients.
Area of Science:
- Oncology
- Immunology
- Biotechnology
Background:
- The immune system (IS) plays a critical role in cancer prevention and progression.
- Tumor immune evasion remains a significant challenge in cancer immunotherapy.
- Triple-negative breast cancer (TNBC) is an aggressive subtype with limited treatment options, despite being immunogenic.
Purpose of the Study:
- To review emerging aptamer-based strategies for cancer immunotherapy.
- To discuss the potential of aptamers in stimulating antitumor immunity against TNBC.
- To highlight aptamers as a promising therapeutic approach for TNBC.
Main Methods:
- Literature review of recent studies on aptamer-based immunotherapy.
- Analysis of aptamer mechanisms in modulating the tumor immune microenvironment.
- Evaluation of aptamer specificity and affinity for therapeutic targets.
Main Results:
- Aptamers offer a novel therapeutic modality similar to monoclonal antibodies.
- Aptamer-based strategies are being explored to enhance immune response against cancer cells.
- Recent advancements show potential for aptamers to boost the IS against TNBC.
Conclusions:
- Aptamers represent a promising tool to overcome immune evasion in TNBC.
- Further research into aptamer-based approaches could lead to more effective immunotherapies for TNBC.
- Aptamers have the potential to significantly improve treatment outcomes for TNBC patients.
Related Concept Videos
01:27Tumor Immunotherapy
596
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
596
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:50Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
01:30Cancer Vaccines
456
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
456